Using the results of genome wide association studies to reduce the burden of disease: A case for type II diabetes?

点击翻译按钮获取中文摘要

Only half of those with type II diabetes (T2D) have been diagnosed. The delay allows for the progression of associated problems like blindness, cardiovascular disease and heart failure. Advances in genetics have helped identify genes increasing the risk of T2D. Using this information, we see whether we can predict if someone will develop the disease. We then determine whether a test at birth followed by preventive measures reduces the problems associated with T2D and helps people live longer.